Dengue Literature Review
Search
Search
Dark mode
Light mode
Explorer
Home
❯
concepts
Folder: concepts
19 items under this folder.
Apr 14, 2026
Antibody-Dependent Enhancement
ADE
immunopathogenesis
FcR
secondary-infection
severe-dengue
IGHG1
plasmablast
scRNA-seq
IgG-affinity
FcgRIIIA
SPR
Apr 14, 2026
Autoimmunity in Dengue
autoimmunity
immune-complex
ANA
CRP
cytokines
molecular-mimicry
NS1
post-dengue
infection-triggered-autoimmunity
thrombocytopenia
endothelial-cells
ADEM
encephalomyelitis
epidemiology
MCTD
myositis
LIA
India
sex-bias
host-factors
adrenocortical-insufficiency
TLR
Taiwan
NHIRD
Apr 14, 2026
Cross-Reactive Antibodies
cross-reactivity
ADE
neutralisation
IgG
IgA
IgM
IgG3
IgG4
serotype
E-protein
NS1
EDI-II
EDIII
flavivirus
diagnostics
vaccine
longitudinal
antibody-kinetics
Apr 14, 2026
Secondary Dengue Infection
secondary-infection
ADE
DHF
DSS
heterotypic
cross-reactive-antibodies
disease-severity
Apr 13, 2026
Cytokine Storm
cytokines
immunopathogenesis
IL-10
TNF-alpha
IFN-alpha
vascular-permeability
plasma-leakage
DHF
DSS
TLR4
NS1
bystander-activation
Apr 13, 2026
Post-Dengue Syndrome
post-dengue-syndrome
sequelae
convalescence
autoimmunity
musculoskeletal
neurological
fatigue
ADEM
epidemiology
Taiwan
Singapore
host-factors
sex-bias
Apr 12, 2026
Antinuclear Antibodies
ANA
antinuclear-antibody
autoimmunity
IIF
HEp-2
prevalence
SLE
healthy-population
viral-infection
acute-dengue
LIA
India
Apr 12, 2026
Asymptomatic Dengue Infection
asymptomatic
subclinical
silent-infection
seroprevalence
FcgRIIa
protection
scRNA-seq
immune-profiling
CD8-T-cells
NK-cells
plasmablasts
Apr 12, 2026
Dengue Clinical Classification
clinical-classification
WHO-2009
warning-signs
DHF
DSS
dengue-fever
severity
diagnosis
triage
Apr 12, 2026
Dengue Neurological Complications
neurological
ADEM
encephalomyelitis
encephalitis
Guillain-Barre
GBS
CNS
neuropathogenesis
DENV-2
DENV-3
post-infectious
molecular-mimicry
Apr 12, 2026
Dengue Pathophysiology
pathophysiology
vascular-permeability
thrombocytopenia
coagulopathy
complement
liver
NS1
TLR4
plasma-leakage
DHF
DSS
Apr 12, 2026
Dengue Vaccine Candidates
vaccines
CYD-TDV
DENVax
TAK-003
TV003
tetravalent
live-attenuated
subunit
ADE
seronegative
phase-III
correlates-of-protection
Apr 12, 2026
Infection-Triggered Autoimmunity
autoimmunity
molecular-mimicry
bystander-activation
epitope-spreading
viral-infection
ANA
autoantibodies
post-infectious
NS1
dengue-specific
ADEM
epidemiology
Apr 12, 2026
NK Cell Responses in Dengue
NK-cells
FcεRIγ
NKG2D
NKp46
CD94
innate-immunity
immunopathogenesis
Apr 12, 2026
NS1 Molecular Mimicry in Dengue
NS1
molecular-mimicry
autoimmunity
platelets
endothelial-cells
PDI
vimentin
HSP60
thrombocytopenia
coagulation
DHF
flavivirus
WGNGCG
Apr 12, 2026
Original Antigenic Sin
original-antigenic-sin
cross-reactive-T-cells
secondary-infection
immunopathology
T-cell-memory
immunodominance
Apr 12, 2026
T Cell Responses in Dengue
CD8-T-cells
CD4-T-cells
MAIT
iNKT
exhaustion
effector
TCR
immunopathogenesis
Apr 12, 2026
Type I Interferon Response in Dengue
interferon
IFN-alpha
innate-immunity
immunopathogenesis
TLR
RIG-I
Apr 12, 2026
Viraemia
viraemia
viremia
DENV-RNA
NS1
acute-phase
diagnosis
disease-severity
sNS1